异基因造血干细胞移植后抗MDA5抗体相关皮肺综合征
单中心回顾性研究纳入83例异基因造血干细胞移植患者,6例抗MDA5抗体阳性,其中4例有间质性肺病、3例出现类似抗MDA5皮损,3例严重呼吸症状且对全身激素抵抗,1例死于严重间质性肺病。
要点
- 移植后患者可检测到抗MDA5抗体,提示存在皮肺综合征。
- 阳性患者可出现间质性肺病和类似抗MDA5的皮肤表现。
- 部分患者呼吸症状严重且对全身激素抵抗,预后差。
核心结论
- 异基因造血干细胞移植后患者可检测到抗MDA5抗体,并表现出与抗MDA5皮肺综合征相似的临床特征。
研究设计与样本
- 单中心回顾性研究,纳入83例异基因造血干细胞移植患者,其中81例在皮肤科或肺科移植后门诊筛查,2例因临床特征可疑被纳入;另用20例无慢性移植物抗宿主病移植后患者血清作对照。
主要发现
- 83例患者中6例抗MDA5抗体阳性,平均年龄43岁(SD 16)。
- 6例阳性患者中4例有间质性肺病,3例出现类似抗MDA5的皮肤表现(指垫炎症、掌部紫罗兰色丘疹、指端溃疡)。
- 3例阳性患者有严重呼吸症状且对全身激素抵抗,1例死于严重间质性肺病。
关键数值与推荐
- 抗MDA5抗体采用免疫斑点法检测。
- 阳性患者中4例有间质性肺病,3例有类似抗MDA5的皮肤表现。
临床怎么用
- 对异基因造血干细胞移植后出现间质性肺病或类似抗MDA5皮损的患者,可考虑检测抗MDA5抗体。
局限性
- 单中心回顾性设计,样本量有限,长期预后需大样本前瞻性研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Chronic graft-vs-host-disease (cGVHD) after allogeneic stem cell transplantation (AHSCT) may resemble autoimmune diseases. Anti-MDA5 (melanoma differentiation-associated gene 5) dermatopulmonary syndrome is a subset of dermatomyositis defined by specific clinical features and detection of anti-MDA5-antibodies in the serum. OBJECTIVE: To characterize the clinical features of patients who underwent AHSCT and screened positively for anti-MDA5 antibodies. DESIGN, SETTING, AND PARTICIPANTS: For this monocentric retrospective study, we exained 81 patients screened for anti-MDA5 antibodies at a specific dermatological or pulmonary postallograft consultation between January 2014 to September 2015 at a National Reference Center; 2 additional patients not seen at this consultation but having clinical features suggestive of anti-MDA5 syndrome were included. Twenty serum samples from patients after AHSCT without cGVHD were used as controls. MAIN OUTCOMES AND MEASURES: Anti-MDA5 antibodies screened using an immunodot assay. RESULTS: Of 83 patients who underwent AHSCT (mean [SD] age, 47 [14] years), 6 patients tested positive for anti-MDA5 antibodies (mean [SD] age, 43 [16] years) including 4 patients with interstitial lung disease and 3 patients with cutaneous clinical features similar to anti-MDA5 skin symptoms encountered in patients who have not undergone AHSCT, namely finger pad inflammation, palmar violaceous papules, and digital ulcerations. Three patients had severe respiratory symptoms resistant to systemic steroids, and 1 patient died of severe interstitial lung disease. CONCLUSIONS AND RELEVANCE: The clinical features and long-term prognosis of patients who underwent AHSCT and test positively for anti-MDA5 antibodies should be evaluated in large prospective studies.
引用
- Lepelletier C, Bengoufa D, Lyes Z, et al. Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation. JAMA Dermatol. 2017. PMID: 27851860. doi:10.1001/jamadermatol.2016.3976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。